Apnimed, Inc. APMD

Set alert

Price alert · APMD

All alert types
15.67 USD +0.27 +1.75%

As of Nov 3, 11:25 AM ET

Bid
15.65 × 1
Ask
15.79 × 1
15.30 Day range 16.99
15.09 52-week range 35.29
YTD
-37.32%
1 year
-37.32%
Open
15.48
Prev close
15.40
Mkt cap
651.94M
Vol
317.36K
Avg vol
459.66K
EPS
7.22
P/E
2.17
Div yield
0.00%
More statistics
Low
15.30
High
16.99
Forward P/E
-6.42
Beta
0.00
Short ratio
1.05
Inst. own
18.53%
Dividend
0.00
Ex-div date
50-d avg
27.74
200-d avg
27.74
1y target
50.33

5Y chart

Chart tools
Interval

Chart is warming up

The five-year price history for APMD has not been loaded yet. Try again in a moment.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 50.33 +221.2% upside
Target (low)
41.00
Target (mean)
50.33
Target (high)
60.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

APMD analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.34-0.54 – 0.000.000.0%00.0%3
Next quarter-0.60-0.80 – -0.590.000.0%00.0%2
Current year-0.06-0.06 – -0.060.000.0%90.85M0.0%1
Next year-3.98-5.55 – -1.39-0.06-6525.0%22.44M-75.3%4

Upgrades and downgrades

The latest rating changes

APMD analyst upgrades and downgrades
DateFirmActionFromTo
Aug 25, 2026LifeSci CapitalInitiated—Outperform
Aug 25, 2026Cantor FitzgeraldInitiated—Overweight
Aug 25, 2026Evercore ISI GroupInitiated—Outperform
Aug 25, 2026B of A SecuritiesInitiated—Buy